These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2904706)

  • 21. Soluble guanylate cyclase of platelets: function and regulation in normal and pathological states.
    Severina IS
    Adv Enzyme Regul; 1992; 32():35-56. PubMed ID: 1353937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the guanylate cyclase activity of human thrombocytes during ADP-inducible aggregation].
    Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
    Biull Eksp Biol Med; 1991 Feb; 111(2):152-4. PubMed ID: 1677293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble guanylyl cyclase is the only enzyme responsible for cyclic guanosine monophosphate synthesis in human platelets.
    Gambaryan S; Subramanian H; Rukoyatkina N; Herterich S; Walter U
    Thromb Haemost; 2013 May; 109(5):973-5. PubMed ID: 23467662
    [No Abstract]   [Full Text] [Related]  

  • 25. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.
    Mülsch A; Lückhoff A; Pohl U; Busse R; Bassenge E
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):119-25. PubMed ID: 2552329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
    Cardoso MH; Morganti RP; Lilla S; Murad F; De Nucci G; Antunes E; Marcondes S
    Eur J Pharmacol; 2010 Feb; 627(1-3):229-34. PubMed ID: 19895807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of soluble coronary arterial guanylate cyclase by SIN-1.
    Schmidt K; Kukovetz WR
    Eur J Pharmacol; 1986 Mar; 122(1):75-9. PubMed ID: 2869962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance.
    Mülsch A; Busse R; Winter I; Bassenge E
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):568-74. PubMed ID: 2570362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.
    Katsuki S; Arnold W; Mittal C; Murad F
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):23-35. PubMed ID: 14978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous modification of nitrovasodilator-induced cyclic GMP formation in human lymphocytes.
    Vuorinen P
    Pharmacol Toxicol; 1992 Jun; 70(6 Pt 1):463-7. PubMed ID: 1359526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates.
    De Caterina R; Giannessi D; Bernini W; Mazzone A
    Thromb Haemost; 1988 Apr; 59(2):207-11. PubMed ID: 3291182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS; Cantor E; Ho E; Walega M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of guanyl cyclase in the regulation of aggregation of human thrombocytes].
    Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
    Vestn Akad Med Nauk SSSR; 1991; (10):51-4. PubMed ID: 1686950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of carnosine on the activation of human platelet soluble guanylate cyclase by sodium nitroprusside and protoporphyrin IX.
    Severina IS; Busygina OG
    Biochem Int; 1990 Nov; 22(3):455-65. PubMed ID: 1981669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo.
    Spiecker M; Darius H; Meyer J
    Thromb Res; 1993 Jun; 70(5):405-15. PubMed ID: 7690993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex and age differences in soluble guanylate cyclase activity in human platelets.
    Michimata T; Imamura M; Mizuma H; Murakami M; Iriuchijima T
    Life Sci; 1996; 58(5):415-9. PubMed ID: 8594306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitroglycerin tolerance at the platelet level in patients with angina pectoris.
    Chirkov YY; Chirkova LP; Horowitz JD
    Am J Cardiol; 1997 Jul; 80(2):128-31. PubMed ID: 9230146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
    Severina IS
    Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase.
    Severina IS; Bussygina OG; Pyatakova NV; Khropov YV; Krasnoperov RA
    Eur J Pharmacol; 2000 Oct; 407(1-2):61-4. PubMed ID: 11050291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.